Psoriatic Arthritis Therapeutics Market by Drug Class (Interleukin Inhibitors, TNF Inhibitors, PDE4 Inhibitors, and Others), by Disease Type (Asymmetric Psoriatic Arthritis, Symmetric Psoriatic Arthritis, Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, Spondylitis, and Arthritis Mutilans), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 01-Jul-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-4271 Status : Published

Global psoriatic arthritis therapeutics market expected to generate around USD 16.71 billion by 2025, at a CAGR of around 11.2% between 2019 and 2025. The global psoriatic arthritis therapeutics market is mainly driven by the increased prevalence of psoriasis that is leading to the rise in the number of psoriatic arthritis patients.

Request Free Brochure of Psoriatic Arthritis Therapeutics Market

Your personal details are safe and secured with us. Privacy Policy SSL site seal - click to verify
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com